Nasacort Aq (Triamcinolone Acetonide)

Nasacort Aq Review

Nasacort is FDA approved for the treatment of the nasal symptoms of seasonal and year round allergies such as nasal congestion, itchy runny nose, and sneezing. Nasacort Nasal Spray is an unscented, thixotropic, water-based metered-dose pump spray formulation unit containing a microcrystalline suspension of triamcinolone acetonide in an aqueous medium.

Buy Nasacort Aq in a reliable US Online Pharmacy
FedEx Next Day Delivery

Nasacort Aq Drug Class and Mechanism

Nasacort Aq Uses

They are also used in the post-operative period of certain cosmetic surgery procedures, notably rhinoplasty. Injected into the subcutaneous area, they may help to alleviate stubborn swelling and decrease the presence of scar tissue. Topical triamcinolone acetonide paste is often prescribed for mouth or gum irritation following dental procedures. Triamcinolone is occasionally used to treat severe cases of hayfever. Also used to treat diabetic retinopathy.Adults and children 12 years of age and older: The recommended starting and maximum dose is 220 mcg per day as two sprays in each nostril once daily.

Nasacort Aq Side Effects

In placebo-controlled, double-blind, and open-label clinical studies, 1483 adults and children 12 years and older received treatment with triamcinolone acetonide aqueous nasal spray. These patients were treated for an average duration of 51 days. In the controlled trials (2 - 5 weeks duration)from which the following adverse reaction data are derived,1394 patients were treated with Nasacort AQ Nasal Spray for an average of 19 days. In a long-term, open-label study,172 patients received treatment for an average duration of 286 days.A total of 602 children 6 to 12 years of age were studied in 3 double-blind, placebo-controlled clinical trials. Of these,172 received 110 mcg/day and 207 received 220 mcg/day of Nasacort AQ Nasal Spray for two, six, or twelve weeks. The longest average durations of treatment for patients receiving 110 mcg/day and 220 mcg/day were 76 days and 80 days, respectively. Only 1%of those patients treated with Nasacort AQ were discontinued due to adverse experiences. No patient receiving 110 mcg/day discontinued due to a serious adverse event and one patient receiving 220 mcg/day discontinued due to a serious event that was considered not drug related. Overall, these studies found the adverse experience profile for Nasacort AQ to be similar to placebo. A similar adverse event profile was observed in pediatric patients 6-12 years of age as compared to older children and adults with the exception of epistaxis which occurred in less than 2%of the pediatric patients studied. Adverse events occurring at an incidence of 2%or greater and more common among adult patients treated with placebo than Nasacort AQ were: headache, and rhinitis. In children aged 6 to 12 years these events included: asthma, epistaxis, headache, infection, otitis media, sinusitis, and vomiting. In clinical trials, nasal septum perforation was reported in one adult patient although relationship to Nasacort AQ Nasal Spray has not been established.

Nasacort Aq Pregnancy

Nasacort Aq Overdose

An overdose of this medication is not likely to occur. If you do think that an overdose has occurred, call an emergency room or poison control left for advice.

Nasacort Aq More Information

Avoid items or activities that are known allergens to you. Clean areas where dust or pet fur may aggravate your condition. Avoid exposing yourself to known sources of infection. Stay away from people with chicken pox, measles, or any other type of infection. Your immune system may not be strong enough to fight off an infection while using Nasacort.